CN102898288A - Difluorovinyl-ether-containing liquid crystal compound and composition and liquid crystal displayer thereof - Google Patents

Difluorovinyl-ether-containing liquid crystal compound and composition and liquid crystal displayer thereof Download PDF

Info

Publication number
CN102898288A
CN102898288A CN2012103885347A CN201210388534A CN102898288A CN 102898288 A CN102898288 A CN 102898288A CN 2012103885347 A CN2012103885347 A CN 2012103885347A CN 201210388534 A CN201210388534 A CN 201210388534A CN 102898288 A CN102898288 A CN 102898288A
Authority
CN
China
Prior art keywords
liquid crystal
group
compound
och
halogenated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN2012103885347A
Other languages
Chinese (zh)
Other versions
CN102898288B (en
Inventor
阮群奇
史志兵
谭玉东
房元飞
储著龙
黄伟
丁文全
丁艳
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jiangsu Hecheng Display Technology Co Ltd
Daxin Materials Corp
Original Assignee
Jiangsu Hecheng Display Technology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jiangsu Hecheng Display Technology Co Ltd filed Critical Jiangsu Hecheng Display Technology Co Ltd
Priority to CN201210388534.7A priority Critical patent/CN102898288B/en
Publication of CN102898288A publication Critical patent/CN102898288A/en
Priority to TW102136572A priority patent/TWI499661B/en
Application granted granted Critical
Publication of CN102898288B publication Critical patent/CN102898288B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Liquid Crystal Substances (AREA)

Abstract

The invention provides difluorovinyl-ether-containing liquid crystal compounds of a general formula (I) and a synthesis method, a composition and use thereof in liquid crystal elements. The novel liquid crystal compound provided by the invention has excellent chemical and physical properties, and lower optical anisotropy and higher dielectric anisotropy than other liquid crystal materials. The liquid crystal composition can be used in liquid crystal elements with the liquid crystal medium, such as TN, STN, TFT, VA, ECB, OCB, LCP, PDLC, BiNem, LC LENS, FFS and IPS liquid crystal elements.

Description

liquid crystal compound containing difluorovinylether, composition thereof and liquid crystal display
Technical Field
The present invention relates to a liquid crystal compound and a composition comprising the same, and more particularly, to a novel difluorovinylether-containing liquid crystal compound and a liquid crystal composition comprising the same.
Background
Physically, substances are classified into three states, namely solid, liquid and gaseous. In nature, most materials exhibit only three states of solid, Liquid and gas depending on temperature, and Liquid Crystal (Liquid Crystal) is a new state of matter different from the ordinary solid, Liquid and gas states, and is a state of matter having both Liquid and Crystal properties in a certain temperature range, also called a Liquid Crystal phase or an intermediate phase, and is also called a fourth state of matter.
Liquid crystals are in many kinds, and naturally occurring and artificially synthesized liquid crystals are in many thousands, but they are basically organic compounds. Liquid crystals are classified into thermotropic liquid crystals, lyotropic liquid crystals, induced liquid crystals and flow-induced liquid crystals, according to the conditions under which the liquid crystal phase is formed.
At present, liquid crystal materials used for display are basically thermotropic liquid crystals. Thermotropic liquid crystals are classified into Smectic (semiconducting) liquid crystals (also called lamellar liquid crystals), Nematic (Nematic) liquid crystals (also called filamentous liquid crystals), and cholesteric (cholesteric) liquid crystals (also called helical liquid crystals) depending on the molecular arrangement order state. The physical properties of these phases are known. The molecular structural features of compounds used in the field of electro-optics are generally a rigid backbone comprising, for example, linked 1, 4-phenylene or 1, 4-cyclohexylene groups or heterocyclic ring systems, which are substituted at positions as far apart from one another as possible by so-called mesogenic groups, such as alkyl, alkoxy or cyano groups.
Liquid-crystalline media used in the electro-optical field consist of mixtures of these compounds, and compounds which do not have a interconversion from the crystalline phase to the liquid-crystalline phase are also used. Liquid crystal mixtures are classified into a dynamic scattering type (DS type), a guest-host type (GH type), a twisted nematic type (TN type), a super twisted nematic type (STN type), a thin film transistor type (TFT type), a ferroelectric type (FLC type), and the like. Liquid crystal materials have been widely used for producing liquid crystal display elements such as electronic computers, various measuring instruments, instrument panels for automobiles, electronic notebooks, cellular phones, computers, and televisions.
Hitherto, liquid crystal materials used therefor have been synthesized into various compounds, and they are suitable for use in accordance with the display mode or driving mode and the use thereof. On the other hand, the demand for improving the performance of liquid crystal display elements has been increasing year by year, and in order to meet this demand, development of novel liquid crystal compounds has been continued.
Disclosure of Invention
The invention aims to provide a novel liquid crystal compound containing difluorovinylether.
Another object of the present invention is to provide a synthesis method for synthesizing the liquid crystal compound.
It is still another object of the present invention to provide a composition comprising the liquid crystal compound.
It is a further object of the present invention to provide a use of the liquid crystal composition in liquid crystal devices, which can be used for liquid crystal devices having liquid crystal media, such as TN, STN, TFT, VA, ECB, OCB, LCP, PDLC, BiNem, LC LENS, FFS, and IPS display modes.
One aspect of the present invention provides a novel liquid crystal compound having a structure represented by general formula (i):
Figure BDA00002251869800021
wherein,
R1and R2Identical or different, each independently selected from the group consisting of-H, -F, -Cl, -CN, -NCS, -SCN, -OCN, -NCO,
Figure BDA00002251869800022
A halogenated or non-halogenated linear or branched alkyl or alkoxy group of 1 to 20 carbon atoms and a halogenated or non-halogenated linear or branched alkenyl or alkenyloxy group of 2 to 20 carbon atoms, wherein, in said R1And said R2At least one of-CH2May be substituted by-O-, -S-, -SiH2-、-CH=CH-、-C≡C-、-CF=CF-、-CH=CF-、
Figure BDA00002251869800023
-CO-O-or-O-CO-substitution, with the proviso that the heteroatoms are not directly linked to one another;
ring A1、A2、A3、A4、A5And A6Are the same or different and are each independently selected from the group consisting of
Figure BDA00002251869800024
Figure BDA00002251869800025
Figure BDA00002251869800026
A cyclic structure of the group;
wherein,
the cyclic structure may also conform to at least one of the following a), b), c) and d):
a) one or more hydrogen atoms in the cyclic structure may be replaced by-D, -F, -Cl, -CN, -CF3、-OCF3、-CH2F、-OCH2F、-CF2H、-OCF2H、-OCH3or-CH3Replacement;
b) one or more-CH in the cyclic structure2-by-O-, -SiH2-, -S-or-CO-substitution, with the proviso that the heteroatoms are not directly connected to one another;
c) in the cyclic structure, one or more-CH-in the aromatic ring structure may be replaced by N;
d) one or more of the ring structuresCan be covered with
Figure BDA00002251869800032
Replacement;
Z1、Z3、Z4and Z5The same or different, each independently selected from the group consisting of carbon-carbon single bond, -CO-O-, -CF2O-、-CH2O-、-OCH2-、-CH2CH2-、-CF2CH2-、-CF=CF-、-CH=CH-、-CH=CF-、-C2F4-、-(CH2)4-、-(CF2)4-、-OCF2CF2O-、-CF2CF2CF2O-、-CH2CH2CF2O-、-OCH2CF2O-、-CH2CF2OCH2-、-CH=CHCF2O-、-CF2OCH=CH-、-CF2OCF=CH-、-CF2OCH=CF-、-CF=CFCF2O-、-CF2OCF=CF-、-CH=CHCH2CH2-、-CH2CH=CHCH2-、-C2H4OCH2-、-OCH2CH2CH2-, -CF = CF = CF-, -C.ident.C-CF = CF-C.ident.C-, -CF = CF-C.ident.C-CF = CF-and-C.ident.C-CF2O-;
a is 0 or 1, b, c and d are the same or different and are each independently 0, 1 or 2.
In some preferred embodiments, R1And R2Same or different, eachIndependently selected from the group consisting of H, -F, -Cl, -CN, -NCS,
Figure BDA00002251869800033
A halogenated or unsubstituted linear or branched alkyl or alkoxy group of 1 to 10 carbon atoms and a halogenated or non-halogenated linear or branched alkenyl or alkenyloxy group of 2 to 10 carbon atoms, wherein, in said R1And said R2At least one of-CH2May be substituted by-O-, -CH = CH-, -C.ident.C-, -CF = CF-, -CH = CF-,
Figure BDA00002251869800034
or-CO-O-substitution, provided that the heteroatoms are not directly linked to one another.
In some preferred embodiments, ring A1、A2、A3、A4、A5And A6Are the same or different and are each independently selected from the group consisting of
Figure BDA00002251869800035
Figure BDA00002251869800036
Figure BDA00002251869800037
Group (d) of (a).
In some preferred embodiments, ring A1、A2、A3、A4、A5And A6Each independently of the other is selected from
Figure BDA00002251869800038
Figure BDA00002251869800039
Figure BDA000022518698000310
A cyclic structure of the group.
In some preferred embodiments, Z1、Z3、Z4And Z5The same or different, each independently selected from the group consisting of-CO-O-, -CF2O-、-CH2O-、-OCH2-、-CH2CH2-、-CF=CF-、-CH=CH-、-(CH2)4-、-C2F4-、-(CF2)4-、-OCF2CF2O-、-CF=CFCF2O-, -C.ident.C-and carbon-carbon single bonds.
In some preferred embodiments, Z1、Z3、Z4And Z5Each independently of the others selected from the group consisting of-CO-O-, -CF2O-、-CH2O-、-CH2CH2-、-CF=CF-、-CH=CH-、-C2F4-、-(CH2)4-、-(CF2)4-、-OCF2CF2O-、-CF=CFCF2O-, -C.ident.C-and carbon-carbon single bonds.
In some preferred embodiments, Z1、Z3、Z4And Z5Each independently of the others from the group consisting of-CF2O-、-CH2O-、-CH2CH2-、-CF=CF-、-CH=CH-、-CF=CFCF2O-, -C.ident.C-and carbon-carbon single bonds.
In some preferred embodiments, a is 0 or 1; b + c + d is less than or equal to 3.
In some preferred embodiments, the compound of formula (i) is particularly preferably one or more of the group consisting of:
Figure BDA00002251869800041
Figure BDA00002251869800061
and
Figure BDA00002251869800062
wherein,
R1and R2The same or different, each independently selected from the group consisting of H, -F, -Cl, -CN, and a halogenated or unsubstituted, linear or branched alkyl or alkoxy group of 1 to 7 carbon atoms, wherein, in said R1And said R2At least one of-CH2May be substituted by-O-, -CH = CH-, -C.ident.C-, -CF = CF-, -CH = CF-,
Figure BDA00002251869800071
or-CO-O-substitution, provided that the heteroatoms are not directly linked to one another.
Another object of the present invention is to provide a process for preparing the above compound, comprising the steps of:
the compound of the general formula (III-2) and sodium hydride form sodium salt, and then react with tetrafluorodibromoethane to obtain a compound of the general formula (III-1); and (3) reducing the compound of the general formula (III-1) by lithium aluminum hydride to obtain the compound of the general formula (III).
Figure BDA00002251869800072
The compound of formula (III) and sodium hydride form a sodium salt which is then reacted with a compound of formula (IV) to give a compound of formula (I).
Figure BDA00002251869800073
The compounds of the general formula (III-2) and the general formula (III) are mainly synthesized by a commercially available intermediate or a commonly known synthesis method, wherein the commonly known synthesis method comprises esterification reaction, witting reaction, carbon-carbon cross-coupling reaction (Suzuki coupling, Negishi coupling, Heck coupling, Sonogashira coupling, transition metal catalysis Grignard reagent cross-coupling reaction and the like), reduction reaction and the like.
The main reaction process is as follows:
1) adding a compound of a general formula (III-2) into anhydrous dimethylformamide solvent under the protection of argon, adding sodium hydride in batches, heating to 60 ℃, reacting for 1 hour, cooling to room temperature, then dropwise adding a dimethylformamide solution of ethyl difluorobromoacetate, and reacting for 12 hours at room temperature to obtain the compound of the general formula (III-1).
Figure BDA00002251869800075
2) Dissolving the compound of the general formula (III-1) in anhydrous acetonitrile, adding zinc powder under the protection of nitrogen, and refluxing for 10-12 h to obtain the compound of the general formula (III).
Figure BDA00002251869800076
3) The compound of the general formula (IV) is dissolved in anhydrous dimethylformamide solvent, N2Adding sodium hydride under the protection, heating to 60 ℃, reacting for 1h, adding the compound of the general formula (III-1), and reacting for 1h at 60 ℃ to obtain the compound of the general formula (V).
Figure BDA00002251869800081
It is a further object of the present invention to provide a liquid crystal composition comprising one or more liquid crystal compounds of formula (I).
In some embodiments, the liquid crystal composition comprises one to five liquid crystal compounds of formula (I), preferably the liquid crystal composition comprises two to four liquid crystal compounds of formula (I).
Further mixing components of the liquid-crystalline composition according to the invention may be generally known mesogenic compounds, i.e. compounds which form liquid-crystalline phases, either neat or mixed with other components. Some such compounds are mentioned for example in D E1804894 and CN 1158602A. Preferably, in some embodiments, the liquid crystal composition further comprises at least one liquid crystal compound of formula (ii):
wherein,
R3and R4The same or different, each independently selected from the group consisting of-H, -F, -Cl, -CN, -NCS, -SCN, -OCN, -NCO, -OCH = CF2And a halogenated or non-halogenated linear or branched alkyl or alkoxy group of 1 to 20 carbon atoms, wherein in said R3And said R4At least one of-CH2May be substituted by-O-, -S-, -SiH2-、-CH=CH-、-C≡C-、-CF=CF-、-CH=CF-、
Figure BDA00002251869800083
-CO-O-or-O-CO-substitution, with the proviso that the heteroatoms are not directly linked to one another;
B1、B2and B3And B4Are the same or different and are each independently selected from the group consisting of
Figure BDA00002251869800084
Figure BDA00002251869800085
2, 3-difluoro-1, 4-phenylene, 3-fluoro-1, 4-phenylene, 2-chloro-3-fluoro-1, 4-phenylene, 2, 6-difluoro-1, 4-phenylene, 3, 5-difluoro-1, 4-phenylene, indan-2, 5-diyl, piperidine-1, 4-diyl, naphthalene-2, 6-diyl, decahydronaphthalene-2, 6-diyl, and 1,2,3, 4-tetrahydronaphthalene-2, 6-diylOne or two non-adjacent-CH2-may be replaced by-O-or-S-, saidOne or more of H may each independently be substituted by F, said
Figure BDA00002251869800088
One or two non-adjacent-CH-s may be replaced by N, said
Figure BDA00002251869800089
One or two non-adjacent-CH2May be replaced by O, said
Figure BDA000022518698000810
Each of the one or more H may be independently substituted with F;
Y1、Y2and Y3The same or different, each independently selected from the group consisting of-OCO-, -CO-O-, -CF2O-、-CH2O-、-OCH2-、-CH2CH2-、-CF2CH2-、-CF=CF-、-CH=CH-、-CH(CH3)CH2-、-CH2CH(CH3)-、-(CH2)3O-、-O(CH2)3-、-COS-、-SCO-、-CH=CF-、-C2F4-、-(CH2)4-、-C4F8-、-OCF2CF2O-、-CF2CF2CF2O-、-CH2CH2CF2O-、-CH2CF2OCH2-、-CH=CHCF2O-、-CF2OCH=CH-、-CF2OCF=CH-、-CF2OCH=CF-、-CF=CFCF2O-、-CF2OCF=CF-、-CH=CHCH2CH2-、-C2H4OCH2-、-CH2CH=CHCH2-、-OCH2CH2CH2-、-CF=CF-CF=CF-、-C≡C-CF=CF-、-C≡C-CF=CF-C≡C-、-CF=CF-C≡C-CF=CF-、-C≡C-CF2O-, -C ≡ C-and a single bond, wherein in the Y1And Y2Any one of-CH2May be-SiH2-substitution;
m, n and p are the same or different and are each independently 0, 1 or 2.
The liquid crystal compound is selected from the group consisting of:
Figure BDA00002251869800091
Figure BDA00002251869800101
Figure BDA00002251869800111
and
Figure BDA00002251869800112
in some embodiments, the liquid crystal composition comprises 5 to 50% by weight of the total weight of the liquid crystal composition of a compound of formula (I); 50-95% of the compound of formula (II) by total weight of the liquid crystal composition, preferably 10-30% of the compound of formula (I) by total weight of the liquid crystal composition; 70-90% of the compound of the general formula (II) based on the total weight of the liquid crystal composition.
It is still another object of the present invention to provide a liquid crystal display comprising a liquid crystal composition comprising the liquid crystal compound of the present invention.
It is still another object of the present invention to provide a novel difluorovinylether-containing liquid crystal compound which is suitable as a composition of a liquid crystal medium and applicable to liquid crystal devices containing a liquid crystal medium, such as TN, STN, TFT, VA, ECB, OCB, LCP, PDLC, BiNem, LC LENS, FFS, and IPS display mode liquid crystal devices.
The novel hexahydroindene-containing liquid crystal compound provided by the invention has good chemical and physical properties, and has lower viscosity, larger optical anisotropy and larger dielectric anisotropy compared with other liquid crystal materials.
Detailed Description
The invention will be illustrated below with reference to specific embodiments. It should be noted that the following examples are illustrative of the present invention, and are not intended to limit the present invention. Other combinations and various modifications within the spirit or scope of the present invention may be made without departing from the spirit or scope of the present invention.
For convenience of expression, in the following examples, the group structures of the liquid crystal compounds are represented by the codes listed in Table 1:
TABLE 1 radical structural code of liquid crystal compounds
Figure BDA00002251869800121
Compounds of the following formula are exemplified:
Figure BDA00002251869800122
the structural formula is represented by the code listed in Table 1, and can be expressed as: 3PUQUF, Q in the code represents difluoromethyleneoxy; c in the code represents cyclohexane; u in the code represents 2, 5-difluorophenylene.
Example 1
The synthetic route of the compound HCLC-12 prepared is shown below,
Figure BDA00002251869800131
the specific process steps are as follows:
1) synthesis of HCLC-12-2
Adding 21.8g of propiophenol and 200mL of Dimethylformamide (DMF) into a 500mL three-neck flask, dissolving, adding 8g of 60% sodium hydride (NaH) under the protection of nitrogen, heating to 60 ℃, reacting for 1h, cooling to 30 ℃, dropwise adding 31.2g of tetrafluorodibromoethane, and reacting for 12h at room temperature. Adding ethyl acetate 200ml and water 200ml, layering, extracting water layer with ethyl acetate 200ml, combining organic layers, washing with water for 2 times, washing with brine twice, drying and concentrating to obtain crude product 38.5g, and crude petroleum ether passing through column to obtain 34 g. GC: 98.8% and yield 85.6%.
2) Synthesis of HCLC-12-1
20g of HCLC-12-2, 6g of zinc powder and 100ml of acetonitrile are added into a 250ml reaction bottle, reflux is carried out for 11h under nitrogen, the temperature is reduced to room temperature, and the crude product is obtained after suction filtration and spin drying. After the crude product is dissolved by adding petroleum ether, the petroleum ether is eluted and passes through a column, and the product is dried by spinning to obtain 13.4 g. Yield 89%, GC: 86.3 percent.
3) Synthesis of HCLC-12
A250 ml reaction flask was charged with 1.9g of 60% sodium hydride NaH, 3.2g of 2, 3-difluoro-4-ethoxyphenol and 100ml of DMF, N2Heating to 60 ℃ to react for 1h, adding 6g of HCLC-12-1, reacting at 60 ℃ for 6h, adding 300ml of water and 200ml of ethyl acetate to extract, washing with water, washing with brine, drying, concentrating, performing petroleum ether column chromatography to obtain 8.4g of colorless oily substance, and recrystallizing with 10ml of ethanol at-30 ℃ for four times to obtain 1.97g of colorless transparent oily substance, wherein GC: 99.7% and a yield of 25%.
1H NMR(300MHz,CDCl3)δ7.50-7.21(m,2H),6.94-6.76(m,2H),6.55-6.60(m,2H),4.09(q,J=11.8Hz,2H),2.69-2.73(m,1H),1.89-1.09(m,16H),0.93-0.82(m,3H)。
Example 2
The synthetic route of the compound HCLC-12K prepared is shown as follows,
Figure BDA00002251869800141
[4, 4-difluoro- (3,4, 5-trifluorophenoxy) methyl ] -3, 5-difluorophenylboronic acid can be synthesized by a method known in the art (see European Journal of Organic Chemistry, 2008, V20p 3479-3487).
The specific process steps are as follows:
1) synthesis of HCLC-12K-4
Adding 15g of p-propylphenol and 150mL of DMF into a 250mL three-neck flask, dissolving, adding 4.4g of sodium hydride (NaH) under the protection of nitrogen, heating to 60 ℃, reacting for 1h, cooling to 30 ℃, dropwise adding 36g of tetrafluorodibromoethane, and reacting for 12h at room temperature. Adding 200ml ethyl acetate and 200ml water, separating layers, extracting water layer with 200ml ethyl acetate, combining organic layers, washing with water for 2 times, washing with brine for two times, drying and concentrating to obtain crude product 30g, and passing petroleum ether crude product through column to obtain 22.5 g. GC: 96.5% and yield 64.8%.
2) Synthesis of HCLC-12K-3
22.5g of HCLC-12K-4, 10g of zinc powder and 150ml of acetonitrile are added into a 250ml reaction bottle, reflux is carried out for 11h under nitrogen, the temperature is reduced to room temperature, suction filtration and spin drying are carried out, and a crude product is obtained. The crude product is dissolved by adding petroleum ether, and then the solution is passed through a column and is dried by spinning to obtain 9.6g of a product. Yield 62.3%, GC: 85.8 percent.
3) Synthesis of HCLC-12K-2
A1L dry clean single neck flask was charged with 20g of p-hydroxyphenylboronic acid, 43.5g of 3-fluoro-4-iodobromobenzene, 30.5g of anhydrous sodium carbonate, 144mL of deionized water, 160mL of toluene and 80mL of anhydrous ethanol, purged with argon, and then 0.5g of Pd [ P (Ph)3]4. Heating and refluxing for 6h under the protection of argon, cooling the reaction liquid, separating the liquid, drying 20g of anhydrous sodium sulfate, evaporating the toluene of the organic phase, passing through a silica gel column, eluting with 3:1 petroleum ether and ethyl acetate, evaporating the solvent of the chromatographic liquid by using a rotary evaporator to obtain 42g of light yellow solid, and recrystallizing the crude product by using 100mL of anhydrous ethanol and 100mL of toluene to obtain 31.5g of white solid, wherein the GC content is 99.6%, and the yield is 82%.
4) Synthesis of HCLC-12K-1
A250 mL dry clean single-neck bottle was charged with 6g of HCLC-12K-2, 8g of [4, 4-difluoro- (3,4, 5-trifluorophenoxy) methyl]-3, 5-difluorophenylboronic acid, 4.8g of anhydrous sodium carbonate, 25mL of deionized water, 100mL of toluene, and 25mL of anhydrous ethanol, purged with argon, and then 0.5g of Pd [ P (Ph)3]4. Heating and refluxing for 12h under the protection of argon, cooling the reaction liquid, separating the liquid, evaporating the organic phase to remove toluene, passing through a silica gel column, eluting with 3:1 petroleum ether and ethyl acetate, evaporating the solvent from the chromatographic solution by using a rotary evaporator to obtain 11g of light yellow solid, and recrystallizing the crude product by using 20mL of toluene and 10mL of anhydrous ethanol to obtain 9.5g of white solid, wherein the GC content is 99.7%, and the yield is 85%.
5) Synthesis of HCLC-12K
0.7 is added into a 100ml reaction bottleg60%NaH、5g HCLC-12K-1、50ml DMF,N2Heating to 60 ℃ for reaction for 1h, adding 3.0g of HCLC-12K-3, reacting at 60 ℃ for 1h, adding 100ml of water and 200ml of ethyl acetate for extraction, washing with water, washing with brine, drying, concentrating, passing through a silica gel column, eluting with 5:1 petroleum ether and ethyl acetate, evaporating the solvent of the chromatographic solution by using a rotary evaporator to obtain 6.4g of colorless oily matter, recrystallizing with 15ml of toluene and 20ml of ethanol for four times to obtain 2.9g of white solid, and performing GC: 99.6% and a yield of 42%.
1H NMR(300MHz,CDCl3)δ7.94(dd,J=15.0,10.1Hz,1H),7.71(dd,J=16.0,3.0Hz,1H),7.62–7.53(m,2H),7.36–7.28(m,,2H),7.08–6.97(m,3H),6.95–6.76(m,6H),2.61(t,J=15.5Hz,2H),1.74–1.55(m,2H),0.94(t,J=13.2Hz,3H)。
Example 3
The synthetic route of the compound HCLC-12M prepared is shown below,
Figure BDA00002251869800151
the specific process steps are as follows:
1) synthesis of HCLC-12M-1
A250 mL dry clean single-neck bottle was charged with 4g of p-bromophenol, 7.8g of [4, 4-difluoro- (3,4, 5-trifluorophenoxy) methyl]-3, 5-difluorophenylboronic acid, 4.8g of anhydrous sodium carbonate, 25mL of deionized water, 100mL of toluene, and 25mL of anhydrous ethanol, purged with argon, and then 0.5g of Pd [ P (Ph)3]4. Heating and refluxing for 12h under the protection of argon, cooling the reaction liquid, separating the liquid, evaporating the organic phase to remove toluene, passing through a silica gel column, eluting with 3:1 petroleum ether and ethyl acetate, evaporating the solvent from the chromatographic solution by using a rotary evaporator to obtain 9.2g of light yellow solid, and recrystallizing the crude product twice by using 20mL of absolute ethyl alcohol to obtain 8.1g of white solid, wherein the GC content is 99.6%, and the yield is 87%.
2) Synthesis of HCLC-12M
A100 ml reaction flask was charged with 0.7g60% NaH, 5g HCLC-12M-1 and 50ml DMF, N2Heating to 60 ℃ for reaction for 1h, adding 2.6g of HCLC-12K-3, reacting at 60 ℃ for 1h, adding 100ml of water and 200ml of ethyl acetate for extraction, washing with water, washing with brine, drying, concentrating, passing through a silica gel column, eluting with 5:1 petroleum ether and ethyl acetate, evaporating the solvent of the chromatographic solution by using a rotary evaporator to obtain 6.9g of colorless oily matter, and recrystallizing with 20ml of petroleum ether and 20ml of ethanol for four times to obtain 2.9g of white solid, and performing GC: 99.6%, yield 39%.
1H NMR(300MHz,CDCl3)δ7.62–7.53(m,2H),7.29–7.35(m,2H),7.06–6.97(m,2H),6.93–6.76(m,6H),2.61(t,J=15.6Hz,2H),1.74–1.55(m,2H),0.94(t,J=13.2Hz,3H)。
Example 4
The synthetic route of the prepared compound HCLC-12N is shown as follows,
Figure BDA00002251869800161
when synthesizing HCLC-12N-1, according to the method for synthesizing HCLC-12M-1, 3-fluoro-4-bromophenol is used to replace p-bromophenol for synthesis, and then according to the method for synthesizing compound HCLC-12M, white solid HCLC-12N can be obtained.
1H NMR(300MHz,CDCl3)δ7.62-7.57(m,1H),7.27-7.09(m,5H),6.95-6.83(m,4H),6.53-6.62(m,1H),2.62(t,J=15.6Hz,2H),1.68-1.55(m,2H),0.93(t,J=13.2Hz,3H)。
Example 5 below is the results of a performance test of a liquid crystal composition of the invention:
the abbreviated codes of the test items in the following examples are as follows:
cp (. degree. C.): clearing points (nematic-isotropic phase transition temperature)
Eta: flow viscosity (mm)2·s-120 ℃ unless otherwise stated)
Δ n: optical anisotropy (589 nm, 20 ℃ C.)
Δ ε: dielectric anisotropy (1 KHz, 25 ℃ C.)
Example 5
Table 2 shows the liquid crystal compositions of HCLC-12K and HCLC-12M and the corresponding parameters obtained:

Claims (15)

1. A compound of formula (I):
wherein,
R1and R2Identical or different, each independently selected from the group consisting of-H, -F, -Cl, -CN, -NCS, -SCN, -OCN, -NCO,
Figure FDA00002251869700012
A halogenated or non-halogenated linear or branched alkyl or alkoxy group of 1 to 20 carbon atoms and a halogenated or non-halogenated linear or branched alkenyl or alkenyloxy group of 2 to 20 carbon atoms, wherein, in said R1And said R2At least one of-CH2May be substituted by-O-, -S-, -SiH2-、-CH=CH-、-C≡C-、-CF=CF-、-CH=CF-、
Figure FDA00002251869700013
-CO-O-or-O-CO-substitution, with the proviso that the heteroatoms are not directly linked to one another;
ring A1、A2、A3、A4、A5And A6Are the same or different and are each independently selected from the group consisting of
Figure FDA00002251869700014
Figure FDA00002251869700015
Figure FDA00002251869700016
A cyclic structure of the group;
optionally, the cyclic structure further conforms to at least one of the following a), b), c) and d):
a) one or more hydrogen atoms in the cyclic structure may be replaced by-D, -F, -Cl, -CN, -CF3、-OCF3、-CH2F、-OCH2F、-CF2H、-OCF2H、-OCH3or-CH3Replacement;
b) one or more-CH in the cyclic structure2-by-O-, -SiH2-, -S-or-CO-substitution, with the proviso that the heteroatoms are not directly connected to one another;
c) in the cyclic structure, one or more-CH-in the aromatic ring structure may be replaced by N;
d) one or more of the ring structures
Figure FDA00002251869700017
Can be covered with
Figure FDA00002251869700018
Replacement;
Z1、Z3、Z4and Z5The same or different, each independently selected from the group consisting of carbon-carbon single bond, -CO-O-, -CF2O-、-CH2O-、-OCH2-、-CH2CH2-、-CF2CH2-、-CF=CF-、-CH=CH-、-CH=CF-、-C2F4-、-(CH2)4-、-(CF2)4-、-OCF2CF2O-、-CF2CF2CF2O-、-CH2CH2CF2O-、-OCH2CF2O-、-CH2CF2OCH2-、-CH=CHCF2O-、-CF2OCH=CH-、-CF2OCF=CH-、-CF2OCH=CF-、-CF=CFCF2O-、-CF2OCF=CF-、-CH=CHCH2CH2-、-CH2CH=CHCH2-、-C2H4OCH2-、-OCH2CH2CH2-, -CF = CF = CF-, -C.ident.C-CF = CF-C.ident.C-, -CF = CF-C.ident.C-CF = CF-and-C.ident.C-CF2O-;
a is 0 or 1, b, c and d are the same or different and are each independently 0, 1 or 2.
2. A compound of claim 1, wherein R is1And R2The same or different, each independently selected from the group consisting of H, -F, -Cl, -CN, -NCS,
Figure FDA00002251869700021
A halogenated or unsubstituted linear or branched alkyl or alkoxy group of 1 to 10 carbon atoms and a halogenated or non-halogenated linear or branched alkenyl or alkenyloxy group of 2 to 10 carbon atoms, wherein, in said R1And stationR is2At least one of-CH2May be substituted by-O-, -CH = CH-, -C.ident.C-, -CF = CF-, -CH = CF-,
Figure FDA00002251869700022
or-CO-O-substitution, provided that the heteroatoms are not directly linked to one another.
3. The compound of claim 1, wherein ring a is1、A2、A3、A4、A5And A6Are the same or different and are each independently selected from the group consisting of
Figure FDA00002251869700023
Figure FDA00002251869700024
Figure FDA00002251869700025
Group (d) of (a).
4. The compound of claim 3, wherein ring A is1、A2、A3、A4、A5And A6Each independently of the other is selected from
Figure FDA00002251869700026
Figure FDA00002251869700028
A cyclic structure of the group.
5. The compound of claim 1, wherein Z is1、Z3、Z4And Z5The same or different, each being independentSelected from-CO-O-, -CF2O-、-CH2O-、-OCH2-、-CH2CH2-、-CF=CF-、-CH=CH-、-(CH2)4-、-C2F4-、-(CF2)4-、-OCF2CF2O-、-CF=CFCF2O-, -C.ident.C-and carbon-carbon single bonds.
6. A compound according to claim 5, wherein Z is1、Z3、Z4And Z5Each independently of the others selected from the group consisting of-CO-O-, -CF2O-、-CH2O-、-CH2CH2-、-CF=CF-、-CH=CH-、-C2F4-、-(CH2)4-、-(CF2)4-、-OCF2CF2O-、-CF=CFCF2O-, -C.ident.C-and carbon-carbon single bonds.
7. The compound of claim 6, wherein Z is1、Z3、Z4And Z5Each independently of the others from the group consisting of-CF2O-、-CH2O-、-CH2CH2-、-CF=CF-、-CH=CH-、-CF=CFCF2O-, -C.ident.C-and carbon-carbon single bonds.
8. The compound of claim 1, wherein a is 0 or 1; b + c + d is less than or equal to 3.
9. The compound of claims 1-8, wherein the compound is selected from the group consisting of:
Figure FDA00002251869700031
Figure FDA00002251869700041
Figure FDA00002251869700051
and
Figure FDA00002251869700052
wherein,
R1and R2The same or different, each independently selected from the group consisting of H, -F, -Cl, -CN, and a halogenated or unsubstituted, linear or branched alkyl or alkoxy group of 1 to 7 carbon atoms, wherein, in said R1And said R2At least one of-CH2May be substituted by-O-, -CH = CH-, -C.ident.C-, -CF = CF-, -CH = CF-,
Figure FDA00002251869700053
or-CO-O-substitution, provided that the heteroatoms are not directly linked to one another.
10. Liquid crystal composition comprising at least one compound according to one of claims 1 to 9.
11. Liquid crystal composition according to claim 10, characterized in that it comprises one to five liquid crystal compounds according to one of claims 1 to 10, preferably the liquid crystal mixture comprises two to four liquid crystal compounds according to one of claims 1 to 10.
12. The liquid crystal composition of claim 10, further comprising at least one liquid crystal compound of formula ii:
Figure FDA00002251869700061
wherein,
R3and R4The same or different, each independently selected from the group consisting of-H, -F, -Cl, -CN, -NCS, -SCN, -OCN, -NCO, -OCH = CF2A halogenated or non-halogenated linear or branched alkyl or alkoxy group of 1 to 20 carbon atoms and a halogenated or non-halogenated linear or branched alkenyl or alkenyloxy group of 2 to 20 carbon atoms, wherein in said R3And said R4At least one of-CH2May be substituted by-O-, -S-, -SiH2-、-CH=CH-、-C≡C-、-CF=CF-、-CH=CF-、
Figure FDA00002251869700062
-CO-O-or-O-CO-substitution, with the proviso that the heteroatoms are not directly linked to one another;
B1、B2and B3And B4Are the same or different and are each independently selected from the group consisting of
Figure FDA00002251869700063
Figure FDA00002251869700064
2, 3-difluoro-1, 4-phenylene, 3-fluoro-1, 4-phenylene, 2-chloro-3-fluoro-1, 4-phenylene, 2, 6-difluoro-1, 4-phenylene, 3, 5-difluoro-1, 4-phenylene, indan-2, 5-diyl, piperidine-1, 4-diyl, naphthalene-2, 6-diyl, decahydronaphthalene-2, 6-diyl, and 1,2,3, 4-tetrahydronaphthalene-2, 6-diyl, wherein said
Figure FDA00002251869700065
One or two non-adjacent-CH2-may be replaced by-O-or-S-, said
Figure FDA00002251869700066
One or more of H may each independently be substituted by F, said
Figure FDA00002251869700067
One or two non-adjacent-CH-s may be replaced by N, said
Figure FDA00002251869700068
One or two non-adjacent-CH2May be replaced by O, saidEach of the one or more H may be independently substituted with F;
Y1、Y2and Y3The same or different, each independently selected from the group consisting of-OCO-, -CO-O-, -CF2O-、-CH2O-、-OCH2-、-CH2CH2-、-CF2CH2-、-CF=CF-、-CH=CH-、-CH(CH3)CH2-、-CH2CH(CH3)-、-(CH2)3O-、-O(CH2)3-、-COS-、-SCO-、-CH=CF-、-C2F4-、-(CH2)4-、-C4F8-、-OCF2CF2O-、-CF2CF2CF2O-、-CH2CH2CF2O-、-CH2CF2OCH2-、-CH=CHCF2O-、-CF2OCH=CH-、-CF2OCF=CH-、-CF2OCH=CF-、-CF=CFCF2O-、-CF2OCF=CF-、-CH=CHCH2CH2-、-C2H4OCH2-、-CH2CH=CHCH2-、-OCH2CH2CH2-、-CF=CF-CF=CF-、-C≡C-CF=CF-、-C≡C-CF=CF-C≡C-、-CF=CF-C≡C-CF=CF-、-C≡C-CF2O-, -C ≡ C-and a single bond, wherein in the Y1And Y2Any one of-CH2May be-SiH2-substitution;
m, n and p are the same or different and are each independently 0, 1 or 2.
13. The liquid crystal composition of claim 12, wherein the liquid crystal compound of formula (ii) is selected from the group consisting of:
Figure FDA000022518697000610
Figure FDA00002251869700071
Figure FDA00002251869700081
and
Figure FDA00002251869700091
14. the liquid crystal composition of claims 10-13, wherein the liquid crystal composition comprises 5-50% by weight of the total weight of the liquid crystal composition of the compound of formula i; 50-95% of the compound of formula II based on the total weight of the liquid crystal composition, preferably, the liquid crystal composition comprises 10-30% of the compound of formula (I) based on the total weight of the liquid crystal composition; 70-90% of the compound of the general formula (II) based on the total weight of the liquid crystal composition.
15. A liquid crystal display comprising the liquid crystal composition according to any one of claims 10 to 14.
CN201210388534.7A 2012-10-13 2012-10-13 Difluorovinyl-ether-containing liquid crystal compound and composition and liquid crystal displayer thereof Active CN102898288B (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CN201210388534.7A CN102898288B (en) 2012-10-13 2012-10-13 Difluorovinyl-ether-containing liquid crystal compound and composition and liquid crystal displayer thereof
TW102136572A TWI499661B (en) 2012-10-13 2013-10-09 A liquid crystal compound having difluoro-vinyl diether-based structure, a liquid crystal composition comprising said compound and applicaton thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201210388534.7A CN102898288B (en) 2012-10-13 2012-10-13 Difluorovinyl-ether-containing liquid crystal compound and composition and liquid crystal displayer thereof

Publications (2)

Publication Number Publication Date
CN102898288A true CN102898288A (en) 2013-01-30
CN102898288B CN102898288B (en) 2014-08-13

Family

ID=47570813

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201210388534.7A Active CN102898288B (en) 2012-10-13 2012-10-13 Difluorovinyl-ether-containing liquid crystal compound and composition and liquid crystal displayer thereof

Country Status (2)

Country Link
CN (1) CN102898288B (en)
TW (1) TWI499661B (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103361074A (en) * 2013-07-01 2013-10-23 江苏和成新材料有限公司 Liquid-crystal compound containing polyfluorinated unsaturated indene ring as well as composite and application thereof
CN109061976A (en) * 2017-06-13 2018-12-21 江苏和成显示科技有限公司 A kind of liquid crystal display device and its application
CN109085725A (en) * 2017-06-13 2018-12-25 江苏和成显示科技有限公司 A kind of liquid crystal display device and its application

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104402683B (en) * 2014-11-21 2017-02-01 石家庄诚志永华显示材料有限公司 Liquid crystal compound and liquid crystal mixture containing same

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5545218B2 (en) * 2008-10-27 2014-07-09 Jnc株式会社 Liquid crystal composition and liquid crystal display element

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
ALEXEI I.MUSHTA ET AL.: "Synthesis and some chemical properties of 1-aryloxy-2-chloro-1,2-difluoroethenes", 《JOURNAL OF FLUORINE CHEMISTRY》 *
JUSTIN D.MOODY ET AL.: "Synthesis of internal fluorinated alkenes via facile aryloxylation of substituted phenols with aryl trifluorovinyl ethers", 《ORGANIC & BIOMOLECULAR CHEMISTRY》 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103361074A (en) * 2013-07-01 2013-10-23 江苏和成新材料有限公司 Liquid-crystal compound containing polyfluorinated unsaturated indene ring as well as composite and application thereof
CN103361074B (en) * 2013-07-01 2015-08-26 江苏和成新材料有限公司 Comprise polyfluoro for the liquid crystalline cpd of unsaturated indenes ring and composition thereof and application
CN109061976A (en) * 2017-06-13 2018-12-21 江苏和成显示科技有限公司 A kind of liquid crystal display device and its application
CN109085725A (en) * 2017-06-13 2018-12-25 江苏和成显示科技有限公司 A kind of liquid crystal display device and its application

Also Published As

Publication number Publication date
CN102898288B (en) 2014-08-13
TW201414812A (en) 2014-04-16
TWI499661B (en) 2015-09-11

Similar Documents

Publication Publication Date Title
CN109134423B (en) Compound, liquid crystal composition thereof and photoelectric display device
JP6797544B2 (en) Fluorinated dibenzofuran and dibenzothiophene derivatives
CN108531196B (en) Liquid crystal compound containing dibenzofuran ring and preparation method and application thereof
TWI550071B (en) Orthoester compound,liquid crystal composition and liquid crystal display device
CN107207965B (en) Nematic liquid crystal composition and liquid crystal display element using same
JP4044617B2 (en) Liquid crystalline compound having negative dielectric anisotropy value, liquid crystal composition, and liquid crystal display device
TWI507386B (en) Cycloheptane derivative and preparation method and application thereof
JP5392256B2 (en) Liquid crystal compound having negative dielectric anisotropy, liquid crystal composition, and liquid crystal display device
EP1860089B1 (en) Difluorobenzene derivative and nematic liquid crystal composition making use of the same
KR20120079486A (en) Tetrahydropyran compounds, liquid crystal compositions, and liquid crystal displays containing the compositions
CN113698942A (en) Liquid crystal compound with negative dielectric anisotropy, liquid crystal composition and display device thereof
WO2009136534A1 (en) Liquid crystalline compound with negative dielectric anisotropy, liquid crystal composition, and liquid crystal display device
CN102898288B (en) Difluorovinyl-ether-containing liquid crystal compound and composition and liquid crystal displayer thereof
CN102898272B (en) Containing six hydrogen indenes class novel liquid crystals and composition thereof and application in a liquid crystal display
CN103058836A (en) Liquid crystal compound containing indan and difluoro methylenedioxy bridge, as well as preparation method and application thereof
CN102898287B (en) Novel two fluoro second two ethers liquid crystal and compositions thereof
CN102898414B (en) Novel dioxa saturation naphthalene nucleus liquid crystal compound, composition of liquid crystal compound and application of liquid crystal compound
JP5077621B2 (en) Difluorobenzene derivative and liquid crystal composition using the same
JPH0393741A (en) Optically active compounds for use as chiral doping agent for liquid crystal and method of its preparation and use thereof
CN109761951A (en) A kind of liquid-crystal compounds and its synthetic method of the structure containing dioxanes
TWI495710B (en) Liquid crystal compound having hexahydro-cyclopenta(1,3)dioxinyl-based structure and liquid crystal composition
TWI608086B (en) A liquid crystal compound having bicyclo[3.3.0] octyl-7-ene-based structure, a liquid crystal composition comprising said compound and applicaton thereof
CN102964324B (en) Containing the liquid crystalline cpd of 4-tetrahydropyrans structure and composition thereof and application
CN102899049A (en) Novel double-halogenated vinyl ether liquid crystal compound and composition of novel double-halogenated vinyl ether liquid crystal compound and liquid crystal display
KR102077868B1 (en) Liquid crystal compound, liquid crystal composition and liquid crystal display device

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C53 Correction of patent of invention or patent application
CB03 Change of inventor or designer information

Inventor after: Ruan Qunqi

Inventor after: Huang Wanyu

Inventor after: Shi Zhibing

Inventor after: Tan Yudong

Inventor after: Fang Yuanfei

Inventor after: Chu Zhulong

Inventor after: Huang Wei

Inventor after: Ding Wenquan

Inventor after: Ding Yan

Inventor after: Wang Junzhi

Inventor before: Ruan Qunqi

Inventor before: Shi Zhibing

Inventor before: Tan Yudong

Inventor before: Fang Yuanfei

Inventor before: Chu Zhulong

Inventor before: Huang Wei

Inventor before: Ding Wenquan

Inventor before: Ding Yan

COR Change of bibliographic data

Free format text: CORRECT: INVENTOR; FROM: RUAN QUNQI SHI ZHIBING TAN YUDONG FANG YUANFEI CHUZHULONG HUANG WEI DING WENQUAN DING YAN TO: RUAN QUNQI SHI ZHIBING TAN YUDONG FANG YUANFEI CHUZHULONG HUANG WEI DING WENQUAN DING YAN WANG JUNZHI HUANG WANYU

ASS Succession or assignment of patent right

Owner name: DAXING MATERIALS CORP.

Effective date: 20140516

C41 Transfer of patent application or patent right or utility model
TA01 Transfer of patent application right

Effective date of registration: 20140516

Address after: 212212 Yangtze River bridge, Jiangsu, Yangzhong, Yangzhong on the eastern side of the road

Applicant after: JIANGSU HECHENG DISPLAY TECHNOLOGY Co.,Ltd.

Applicant after: Daxin Materials Corp.

Address before: 212212 Yangtze River bridge, Jiangsu, Yangzhong, Yangzhong on the eastern side of the road

Applicant before: Jiangsu Hecheng Display Technology Co.,Ltd.

C14 Grant of patent or utility model
GR01 Patent grant
CP03 Change of name, title or address
CP03 Change of name, title or address

Address after: East side of Yangtze River bridge, Yangzhong, Yangzhong, Jiangsu

Co-patentee after: Daxin Materials Corp.

Patentee after: JIANGSU HECHENG DISPLAY TECHNOLOGY Co.,Ltd.

Address before: 212212 Yangtze River bridge, Jiangsu, Yangzhong, Yangzhong on the eastern side of the road

Co-patentee before: Daxin Materials Corp.

Patentee before: Jiangsu Hecheng Display Technology Co.,Ltd.

CP02 Change in the address of a patent holder

Address after: Building 2, Sino Japan Cooperation Innovation Park, No. 16, Zidan Road, Qinhuai District, Nanjing, Jiangsu

Patentee after: JIANGSU HECHENG DISPLAY TECHNOLOGY Co.,Ltd.

Patentee after: Daxin Materials Corp.

Address before: 212212 east side of Yangzhong Yangtze River Bridge, Yangzhong City, Jiangsu Province

Patentee before: JIANGSU HECHENG DISPLAY TECHNOLOGY Co.,Ltd.

Patentee before: Daxin Materials Corp.

CP02 Change in the address of a patent holder